2nd Half of 2021 Stock Market Outlook

NYSE: SPY | SPDR S&P 500 ETF Trust News, Ratings, and Charts

SPY – The stock market (SPY) has continued on a bullish path to start 2021. Yet it is not quite the same glorious bull run we enjoyed from the lows of last year. This market has become more volatile and with less upside potential. However, there is still plenty of money to be made if you look in the right places. That is the very nature of the new presentation I put together. So read on for more info….

I just wanted to share with you my brand new presentation:

2nd Half of 2021 Stock Market Outlook

The title is pretty self-explanatory. So as we are approach the mid-point of the year it is the right time to contemplate what lies ahead for the second half.

First, I start by exploring the bullish arguments. Gladly there are many when you consider the improving economic picture which begets higher corporate earnings. This has always been the main elixir for share price gains.

Interestingly there are two other catalyst at play that should have the market moving higher this year. Unfortunately one of them has a fairly negative slant that leads to greater volatility (maybe you already noticed that at play).

Next we need to flip the script and contemplate the bearish arguments. Gladly there is not much in this category. However, the flickering flames of inflation are a concern we need to keep a close eye on as it has been the precursor to many bear markets of the past.

After balancing out the bullish and bearish arguments I then go on to give a year end target for the S&P 500. Yes, it is higher than now, but not significantly higher. That’s because the easy money has already been made leading to slower gains ahead.

As we come down the home stretch of the webinar I discuss strategies to outperform the market. And my top 12 stocks and 2 ETFs that have the right stuff to excel the rest of the year.

To get full details on the market outlook, trading plan and top picks, then click the link below to watch the presentation now:

2nd Half of 2021 Stock Market Outlook

Steve Reitmeister
…but everyone calls me Reity (pronounced “Righty”)
CEO, StockNews & Editor of Reitmeister Total Return


SPY shares . Year-to-date, SPY has gained 13.86%, versus a % rise in the benchmark S&P 500 index during the same period.


About the Author: Steve Reitmeister


Steve is better known to the StockNews audience as “Reity”. Not only is he the CEO of the firm, but he also shares his 40 years of investment experience in the Reitmeister Total Return portfolio. Learn more about Reity’s background, along with links to his most recent articles and stock picks. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
SPYGet RatingGet RatingGet Rating
.INXGet RatingGet RatingGet Rating
DIAGet RatingGet RatingGet Rating
IWMGet RatingGet RatingGet Rating
QQQGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

2 Best Stocks of All Time!

This bear market has me thinking back to my 2 best trades of all time. That being when I bought Amazon (AMZN) and Booking (BKNG) back in 2001 as they were tumbling down in the midst of a bear market...but now enjoying truly phenomenal gains. Let’s discuss what those investments had in common and how that will help us find more big winners in the years ahead. Read on below for more...

:  |  News, Ratings, and Charts

Bears Back in Charge...What Happens Next?

A month ago the bulls were claiming victory as they created a charge back over 4,000 for the S&P 500 (SPY). Since then that false narrative has been peeled away and investors are more honestly looking at the bleak outlook formed by high inflation and a hawkish Fed. That explains why we are back retesting the June lows. Now we have to ponder what comes next and how to trade our way to profits. Read on below for the full story...

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

:  |  News, Ratings, and Charts

Cut These 2 Stocks From Your Portfolio Right Now

The Fed succeeding in a ‘soft landing’ seems unlikely. Analysts are expecting a recession soon. So, with the rising odds of the Fed raising rates aggressively, it could be wise to steer clear of fundamentally weak stocks Roblox (RBLX) and Affirm Holdings (AFRM). Read on…

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

Read More Stories

More SPDR S&P 500 ETF Trust (SPY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All SPY News